Head To Head Comparison Of 18f-fch And 18f-psma-1007 Pet/ct In Biochemically Relapsed Prostate Cancer Patients Preliminary Results

被引：0
|
作者：
Witkowska-Patena, E. [1 ,2 ]
Gizewska, A. [1 ,2 ]
Dziuk, M. [1 ,2 ]
Misko, J. [1 ,2 ]
Budzynska, A. [1 ,2 ]
Walecka-Mazur, A. [3 ]
机构：
[1] Mil Inst Med, Warsaw, Poland
[2] Affidea Mazovian PET CT Med Ctr, Warsaw, Poland
[3] Synektik Pharma, Kielce, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0138
引用
收藏
页码：S446 / S447
页数：2
相关论文
共 50 条
  • [1] 18F-PSMA-1007 PET/CT in Biochemically Relapsed PCa
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 17N - 17N
  • [2] Anthracosis: a potential pitfall in 18F-FCH PET/CT and 18F-PSMA-1007 PET/CT interpretation
    Cimini, A.
    Ricci, M.
    Marzullo, A.
    Menichini, M.
    Di Stasio, F.
    Di Pietro, M.
    Arabi, H.
    Dadgar, H.
    Gravina, G. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S250 - S250
  • [3] 18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer
    Giesel, Frederik L.
    Kesch, Claudia
    Yun, Mijin
    Cardinale, Jens
    Haberkorn, Uwe
    Kopka, Klaus
    Kratochwil, Clemens
    Hadaschik, Boris A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E497 - E499
  • [4] Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Dziuk, Miroslaw
    Misko, Jolanta
    Budzynska, Anna
    Walecka-Mazur, Agata
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (12) : E629 - E633
  • [5] Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
    Ewa Witkowska-Patena
    Agnieszka Giżewska
    Mirosław Dziuk
    Jolanta Miśko
    Anna Budzyńska
    Agata Walęcka-Mazur
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 343 - 348
  • [6] Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Dziuk, Miroslaw
    Misko, Jolanta
    Budzynska, Anna
    Walecka-Mazur, Agata
    PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (02) : 343 - 348
  • [7] 18F-FCH PET/CT Staging in Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 30N - +
  • [8] Equivocal Radiotracer Uptake on 18F-PSMA-1007 PET/CT in Patients with Prostate Cancer
    Spurr, M.
    Kimura, M.
    Kulshresthra, R.
    Kabala, J.
    Challapalli, A.
    Sakthithasan, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 42
  • [9] Atypical neoplastic solitary focal uptake of 18F-PSMA-1007 in PET/CT in patients with biochemically recurrent prostate cancer
    Antonevskaya, T. L.
    Khalimon, A. I.
    Khodzhibekova, M. M.
    Atakishieva, L. U.
    Khamadeeva, G. F.
    Khodakova, D. Yu.
    Lazutina, T. N.
    Pylova, I. V.
    Volchenko, N. N.
    Leontyev, A. V.
    ONKOUROLOGIYA, 2023, 19 (04): : 131 - 138
  • [10] 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Misko, Jolanta
    Dziuk, Miroslaw
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E401 - E403
12345